News
18h
GlobalData on MSNAdvaMed CEO restates hope for medtech industry tariff exemption amid Trump volte-faceWhile Trump announced a three-month ‘pause’ on tariff levies for most countries, China’s tariffs were increased to 125%.
Global drugmakers and MedTech companies bounced back after U.S. President Donald Trump issued a 90-day pause on reciprocal ...
19h
Zacks Investment Research on MSNSanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar?Sanara MedTech Inc. (SMTI) shares ended the last trading session 8.1% higher at $29.20. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the ...
Without a security-first mindset, even the most groundbreaking innovations can be compromised, putting patient data, trust ...
Lobby groups like the American Hospital Association and AdvaMed have so far failed to get medical devices and critical ...
Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.
"It’s truly a dream role, and I can’t wait for what’s ahead," said Field, who's now chief technology officer at medtech ...
Greenberg Traurig attorneys David Dykeman and Roman Fayerberg answer questions about medtech M&A and IP considerations for ...
State of the City report underscores the city’s transformation into a launchpad for successful emerging businesses generating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results